BiotaX Labs

Company Overview

Snapshot

Founded in February 2020 by Shay Hilel, Naama Geva-Zatorsky, and Dean Light, BiotaX Labs operates with 1–10 employees. The company has completed one funding round, securing investment from First In Ventures and Drive Technion. In June 2022, an Israeli development from BiotaX Labs was announced that aims to replace intrusive medical examinations with a simple at-home test.

Business overview

BiotaX Labs is a Health Tech & Life Sciences company specializing in digital healthcare and medical diagnostics. The company develops deep explainable AI models based on system biology to collect, analyze, and predict multiple disease states, calculating optimal interventions supported by meta-genomic AI analysis. Its core product, CustomBiome's live biotherapeutic production technology, isolates targeted live microbes at the strain level (TaxonAI Output) based on taxonomy or gene functionality. BiotaX Labs packages these microbes as customized live biotherapeutic products to address dysbiosis in a personalized and disease-specific manner, serving the healthcare and pharmaceutical industries.

Strategic signal

In June 2022, BiotaX Labs announced an Israeli development focused on replacing intrusive medical examinations with a simple at-home test. This signals a strategic move towards less invasive diagnostic solutions, potentially broadening patient access and improving the overall patient experience in medical diagnostics. For investors, this highlights the company's commitment to innovation in digital medical diagnostics and its potential to disrupt traditional diagnostic methods.

Company Intelligence Q&A

When was BiotaX Labs founded?

BiotaX Labs was founded in February 2020.

Who are the founders of BiotaX Labs?

The co-founders of BiotaX Labs are Shay Hilel, Naama Geva-Zatorsky, and Dean Light.

What is BiotaX Labs' primary focus in healthcare?

BiotaX Labs focuses on decoding precision medicine through deep explainable AI models and customized live biotherapeutic products to address dysbiosis in a personalized and disease-specific way.

Which investors participated in BiotaX Labs' funding round?

In June 2021, BiotaX Labs received investment from First In Ventures and Drive Technion.

What significant development did BiotaX Labs announce in June 2022?

In June 2022, BiotaX Labs announced an Israeli development designed to replace intrusive medical examinations with a simple at-home test.